Navigation Links
Best Practice Database Adds Research on Merger Integration and Competitive Intelligence
Date:5/20/2008

CHAPEL HILL, N.C., May 20 /PRNewswire/ -- New research that delivers insights into merger and acquisition integration and competitive intelligence data gathering for the pharma industry is now available in the Best Practice Database, an online research repository managed by research and consulting firm Best Practices, LLC.

To review sample key findings and key metrics in these studies, go to a landing page with links to each study at this address: http://www3.best-in-class.com/dr305.htm .

The Database is an online resource containing more than $30 million in proprietary research conducted on behalf of executives from Fortune 500 companies. You can use this tool to quickly locate studies that identify best practices and metrics in the areas most important to you and your company.

Research added this month to the Best Practice Database includes a benchmarking study on the key success factors in the merger & acquisition integration process for pharmaceutical and biotechnology companies. Experienced integration champions noted that often the structure for managing an acquired asset will change over a 12-36 month period. Cost reduction, milestone progress, and performance above or below expected performance targets are key drivers of structure change, according to the study.

Also new to the Database this month are studies that explore how organizations can optimize their competitive intelligence operations while working within defined guidelines and the changing landscape of safety and risk management for the pharma industry.

The new research is available in these Best Practice Database Documents (with ID Number):

-- M&A Integration Excellence: What Bio-Pharma Companies Need to Know

(4997)

-- Safety and Risk Management in the Pharmaceutical Sector (4998)

-- Pharmaceutical Competitive Intelligence Excellence: Optimizing Data

Collection within Approved Guidelines (4999)

To view these studies or other studies in the Database, sign up for our complimentary weekly tour, held on Thursdays at 11 a.m. EDT (GMT-5). To sign up, go to this address: http://www3.best-in-class.com/dw212.htm . If you prefer a different time, simply indicate your preference on the sign up form.

To review abstracts and other information about these studies, go to a landing page with links to each study at this address: http://www3.best-in-class.com/dr305.htm .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, a pharmaceutical research and consulting firm, conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations. For more information, call 919-403-0251 or visit http://www.best-in-class.com/ .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Best Practices Insurance Services Announces Key Additions to Senior Management
2. Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrows Leaders
3. Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes
4. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
5. New Employment Practices Liability Policy from Beazley Offers Major Additional Benefits
6. Discover Talent Management Best Practices June 4-6 -- Registration Ends Friday
7. 1 of the best researchers in general practice
8. Hudson Valley Fertility Opens First Advanced Fertility Practice in the Hudson Valley
9. Three-Day Strike by Hundreds of Security Officers at Kaiser Hospitals Succeeds in Raising Red Flag About Unfair Labor Practices
10. ACP says Medicare cuts will hurt physicians in small practices
11. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Therachat , a ... survey in an infographic on the current state of anxiety in support of National ... anxiety, was conducted in April 2017 and benchmarked general anxiety levels as well as ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... PITTSBURGH, PA (PRWEB) , ... May 22, 2017 , ... ... way to write with a pen. "My wife’s hand was damaged in a firework ... invent something that helps people with manual problems." , He then designed and created ...
(Date:5/22/2017)... ... 22, 2017 , ... Faithfully following pop culture, people today are forever in ... shaped through fitness programs. It carries on to skin nourished, pampered and nurtured to ... radiant smile. CDA has found that just like a perfectly cut and ...
(Date:5/21/2017)... ... May 19, 2017 , ... Chris Cornell, 52, was found dead on the night of Wednesday, ... most respected lead singers in the rock industry would take his own life, but the ... investigates how mental illness played a role in the death of Chris Cornell . ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: